Atlas Trials

Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT)

Clinical trial NCT02687399 · UNKNOWN

Trial details

NCT number
NCT02687399
Sponsor
Thrombotargets Europe S.L
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Degenerative Osteoarthritis
Start date
2016-01-01
Primary completion
2018-09-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.